These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9419043)

  • 1. Noradrenergic blood pressure dysregulation and cytosolic calcium in primary hyperparathyroidism.
    Schiffl H; Sitter T; Lang SM
    Kidney Blood Press Res; 1997; 20(5):290-6. PubMed ID: 9419043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular calcium and blood pressure: comparison between primary hyperparathyroidism and essential hypertension.
    Fardella C; Rodriguez-Portales JA
    J Endocrinol Invest; 1995 Dec; 18(11):827-32. PubMed ID: 8778153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure, left ventricular mass and intracellular calcium in primary hyperparathyroidism.
    Dominiczak AF; Lyall F; Morton JJ; Dargie HJ; Boyle IT; Tune TT; Murray G; Semple PF
    Clin Sci (Lond); 1990 Feb; 78(2):127-32. PubMed ID: 2155737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism.
    Rostaing L; Moreau-Gaudry X; Baron E; Cisterne JM; Monroziès-Bernadet P; Durand D
    Clin Nephrol; 1997 Apr; 47(4):248-55. PubMed ID: 9128792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure in patients with primary hyperparathyroidism before and after parathyroidectomy.
    Broulik PD; Horký K; Pacovský V
    Exp Clin Endocrinol; 1985 Dec; 86(3):346-52. PubMed ID: 4092745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenal responses to subtotal parathyroidectomy for primary hyperparathyroidism.
    Pacifici R; Perry HM; Shieber W; Biglieri E; Droke DM; Avioli LV
    Calcif Tissue Int; 1987 Sep; 41(3):119-23. PubMed ID: 3117338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of parathyroidectomy on hypertension prevalence and circadian blood pressure profile in primary hyperparathyroidism.
    Feldstein CA; Akopian M; Pietrobelli D; Olivieri A; Garrido D
    Clin Exp Hypertens; 2010 May; 32(3):154-8. PubMed ID: 20504122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcitropic hormones, platelet calcium, and blood pressure in essential hypertension.
    Brickman AS; Nyby MD; von Hungen K; Eggena P; Tuck ML
    Hypertension; 1990 Nov; 16(5):515-22. PubMed ID: 2228152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative parathormone level measurement in the management of hyperparathyroidism.
    McHenry CR; Pollard A; Walfish PG; Rosen IB
    Surgery; 1990 Oct; 108(4):801-7; discussion 807-8. PubMed ID: 2218894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension Secondary to PHPT: Cause or Coincidence?
    Schiffl H; Lang SM
    Int J Endocrinol; 2011; 2011():974647. PubMed ID: 21423544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory blood pressure monitoring-derived short-term blood pressure variability in primary hyperparathyroidism.
    Concistrè A; Grillo A; La Torre G; Carretta R; Fabris B; Petramala L; Marinelli C; Rebellato A; Fallo F; Letizia C
    Endocrine; 2018 Apr; 60(1):129-137. PubMed ID: 28702887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic hemodynamic pattern in primary hyperparathyroidism and its changes after parathyroidectomy.
    Valvo E; Bedogna V; Gammaro L; Casagrande P; Ortalda V; Maschio G
    Miner Electrolyte Metab; 1991; 17(3):147-52. PubMed ID: 1779935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of blood pressure in end-stage renal disease with platelet cytosolic free calcium concentration during treatment of renal anemia with recombinant human erythropoietin.
    Schiffl H
    Int J Artif Organs; 1992 Jun; 15(6):343-8. PubMed ID: 1639525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytosolic free calcium in platelets: relationships to blood pressure and indices of systemic calcium metabolism.
    Hvarfner A; Larsson R; Mörlin C; Rastad J; Wide L; Akerström G; Ljunghall S
    J Hypertens; 1988 Jan; 6(1):71-7. PubMed ID: 3351296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sympathetic system function and vascular reactivity in hypercalcemic patients.
    Vlachakis ND; Frederics R; Valasquez M; Alexander N; Singer F; Maronde RF
    Hypertension; 1982; 4(3):452-8. PubMed ID: 7068199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a circulating factor in patients with essential hypertension on intracellular free calcium in normal platelets.
    Lindner A; Kenny M; Meacham AJ
    N Engl J Med; 1987 Feb; 316(9):509-13. PubMed ID: 3807994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medical-surgical integrated approach in the treatment of non-paraneoplasic hyperparathyroidism: our experience].
    Pulvirenti D; Aikaterini T; Campagna A; Ignaccolo L; Giustolisi N; Costa E
    Clin Ter; 2008; 159(5):307-10. PubMed ID: 18998031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone, calcium and blood pressure relationships in primary hyperparathyroidism.
    Richards AM; Espiner EA; Nicholls MG; Ikram H; Hamilton EJ; Maslowski AH
    J Hypertens; 1988 Sep; 6(9):747-52. PubMed ID: 3053896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypotensive effects of nifedipine in patients with primary hyperparathyroidism: case reports.
    Takata Y; Takishita S; Koga T; Nakao Y; Okamura K; Yao T; Takemura K; Fujishima M
    Angiology; 1989 Dec; 40(12):1079-82. PubMed ID: 2596742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of platelet Ca2+ homeostasis by hypertensive plasma factor(s) derived from patients with early-stage renal disease.
    Schiffl H
    Klin Wochenschr; 1991 Dec; 69(20):917-23. PubMed ID: 1665528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.